Panaji, Aug 4 (UNI) Goa's Public Health Department will soon sign a memorandum of understanding with pharmaceutical major Novo Nordis for launching a pilot project to study the trends of diabetes disease in the tourist state, where health parametres are claimed to be very high.
Informing this to mediapersons after the State Cabinet had formally approved the proposal, Chief Minister Digambar Kamat said the company would attempt at studying the ''silent killer'' that involved damage of multiple organs.
The company, a leader in diabetes studies, will undertake a survey and share the information.
It will launch the data collection process during August-December this year by taking blood samples for glycemic content from different sections of the society.
Apart from assessing the prevalence of the disease in Goa, the company will develop a baseline database, train doctors, para medical staff and launch public awareness campaigns on its own.
UNI BM SR NP RL RN1833